Population-level differences in revascularization treatment and outcomes among various United States subpopulations

Table 4 Summary of disparities in acute myocardial infarction co-morbidities and presentation symptoms, care and access to medical resources, and outcomes in Hispanics

Co-morbidities and presentation symptoms

More likely than non-Hispanic whites to have hypertension, diabetes, and renal failure and to lack health insurance[95]

More likely than non-Hispanic whites to be younger and to have diabetes, but less likely to have previous MI or prior revascularization[101]

More likely than non-Hispanic whites to have diabetes[103]

Care/medical resources

Longer door-to-drug and door-to-balloon times than for whites[79]

Longer door-to-drug and door-to-balloon times than for whites[79]

Less likely than whites to receive catheterization or PTCA[104]

Outcomes

Hispanic patients with diabetes somewhat less likely at 5 yr to be dead, have MI, or have stroke than white patients with diabetes[90]

More likely to be dead or re-hospitalized at 1 yr than non-Hispanic whites[95]

In-hospital mortality increases with age and is higher among Hispanic females[105]

MI: Myocardial infarction; PTCA: Percutaneous coronary angioplasty.